Total Payments
$1.4M
2024 Payments
$19.40
Companies
12
Transactions
115
Medicare Patients
2,737
Medicare Billing
$741,759
Payment Breakdown by Category
Consulting$1.3M (93.1%)
Other$89,182 (6.6%)
Travel$2,404 (0.2%)
Food & Beverage$1,198 (0.1%)
Research$856.82 (0.1%)
Education$10.85 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1.3M | 46 | 93.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $89,183 | 24 | 6.6% |
| Travel and Lodging | $2,404 | 8 | 0.2% |
| Food and Beverage | $1,198 | 35 | 0.1% |
| Unspecified | $856.82 | 1 | 0.1% |
| Education | $10.85 | 1 | 0.0% |
Payments by Type
General
$1.4M
114 transactions
Research
$856.82
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celularity Inc. | $1.3M | 47 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $87,695 | 39 | $0 (2020) |
| Merck Sharp & Dohme LLC | $3,793 | 6 | $0 (2024) |
| EISAI INC. | $2,000 | 1 | $0 (2019) |
| Celgene Corporation | $1,127 | 3 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $934.86 | 7 | $0 (2020) |
| Roche TCRC, Inc. | $73.37 | 1 | $0 (2017) |
| Janssen Biotech, Inc. | $53.32 | 3 | $0 (2019) |
| Genentech USA, Inc. | $40.09 | 3 | $0 (2020) |
| EMD Serono, Inc. | $38.46 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19.40 | 1 | Merck Sharp & Dohme LLC ($19.40) |
| 2022 | $80,011 | 5 | Celularity Inc. ($80,000) |
| 2021 | $370,022 | 9 | Celularity Inc. ($370,022) |
| 2020 | $506,801 | 18 | Celularity Inc. ($499,500) |
| 2019 | $277,797 | 30 | Celularity, Inc. ($252,975) |
| 2018 | $92,124 | 30 | Celularity, Inc. ($62,585) |
| 2017 | $34,103 | 22 | E.R. Squibb & Sons, L.L.C. ($29,154) |
All Payment Transactions
115 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/05/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2022 | Celularity Inc. | — | Consulting Fee | Cash or cash equivalent | $20,000.00 | General |
| 11/16/2022 | Celularity Inc. | — | Consulting Fee | Cash or cash equivalent | $20,000.00 | General |
| 10/17/2022 | Celularity Inc. | — | Consulting Fee | Cash or cash equivalent | $20,000.00 | General |
| 09/29/2022 | Celularity Inc. | — | Consulting Fee | Cash or cash equivalent | $20,000.00 | General |
| 07/25/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Education | In-kind items and services | $10.85 | General |
| Category: ONCOLOGY | ||||||
| 08/20/2021 | Celularity Inc. | — | Consulting Fee | Cash or cash equivalent | $40,000.00 | General |
| 07/29/2021 | Celularity Inc. | — | Consulting Fee | Cash or cash equivalent | $90,000.00 | General |
| 06/15/2021 | Celularity Inc. | — | Consulting Fee | Cash or cash equivalent | $40,000.00 | General |
| 05/20/2021 | Celularity Inc. | — | Consulting Fee | Cash or cash equivalent | $40,000.00 | General |
| 04/14/2021 | Celularity Inc. | — | Consulting Fee | Cash or cash equivalent | $40,000.00 | General |
| 03/11/2021 | Celularity Inc. | — | Consulting Fee | Cash or cash equivalent | $40,000.00 | General |
| 02/12/2021 | Celularity Inc. | — | Consulting Fee | Cash or cash equivalent | $40,000.00 | General |
| 01/21/2021 | Celularity Inc. | — | Food and Beverage | In-kind items and services | $22.05 | General |
| 01/15/2021 | Celularity Inc. | — | Consulting Fee | Cash or cash equivalent | $40,000.00 | General |
| 12/18/2020 | Celularity Inc. | — | Consulting Fee | Cash or cash equivalent | $40,000.00 | General |
| 12/01/2020 | Celularity Inc. | — | Consulting Fee | Cash or cash equivalent | $40,000.00 | General |
| 10/30/2020 | Celularity Inc. | — | Consulting Fee | Cash or cash equivalent | $40,000.00 | General |
| 10/27/2020 | E.R. Squibb & Sons, L.L.C. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| 10/01/2020 | Celularity Inc. | — | Consulting Fee | Cash or cash equivalent | $40,000.00 | General |
| 08/28/2020 | Celularity Inc. | — | Consulting Fee | Cash or cash equivalent | $40,000.00 | General |
| 08/13/2020 | Celularity Inc. | — | Consulting Fee | Cash or cash equivalent | $39,500.00 | General |
| 07/28/2020 | Celularity Inc. | — | Consulting Fee | Cash or cash equivalent | $40,000.00 | General |
| 06/30/2020 | Celularity Inc. | — | Consulting Fee | Cash or cash equivalent | $40,000.00 | General |
| 06/23/2020 | E.R. Squibb & Sons, L.L.C. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RESEARCH RELATED PUBLICATION SUPPORT | NOVARTIS PHARMACEUTICALS CORPORATION | $856.82 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 462 | 1,182 | $327,847 | $146,737 |
| 2022 | 7 | 721 | 1,840 | $310,240 | $133,553 |
| 2021 | 6 | 726 | 2,213 | $354,582 | $192,549 |
| 2020 | 11 | 828 | 3,309 | $616,328 | $268,920 |
Total Patients
2,737
Total Services
8,544
Medicare Billing
$741,759
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 118 | 525 | $157,920 | $73,324 | 46.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 233 | 539 | $128,677 | $56,659 | 44.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 77 | 77 | $34,888 | $13,914 | 39.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 41 | $6,362 | $2,841 | 44.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 87 | 422 | $126,600 | $61,933 | 48.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 188 | 411 | $102,750 | $40,964 | 39.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 73 | 73 | $35,770 | $13,414 | 37.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 84 | 100 | $16,200 | $6,779 | 41.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 231 | 741 | $22,230 | $5,319 | 23.9% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2022 | 13 | 30 | $4,800 | $4,781 | 99.6% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2022 | 45 | 63 | $1,890 | $363.71 | 19.2% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2021 | 77 | 401 | $64,160 | $64,221 | 100.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 101 | 415 | $124,500 | $61,985 | 49.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 173 | 388 | $97,000 | $41,900 | 43.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 105 | 136 | $22,032 | $9,323 | 42.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 45 | 45 | $22,050 | $8,973 | 40.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 225 | 828 | $24,840 | $6,145 | 24.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 257 | 805 | $201,250 | $71,157 | 35.4% |
| J2505 | Injection, pegfilgrastim, 6 mg | Office | 2020 | 11 | 20 | $150,000 | $61,844 | 41.2% |
| G9678 | Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a | Office | 2020 | 81 | 382 | $61,120 | $60,790 | 99.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 103 | 406 | $121,800 | $50,264 | 41.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2020 | 254 | 1,099 | $32,970 | $8,202 | 24.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 45 | 45 | $22,050 | $8,026 | 36.4% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2020 | 26 | 56 | $22,400 | $7,393 | 33.0% |
| 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | Office | 2020 | 16 | 28 | $2,800 | $813.58 | 29.1% |
About Dr. Andrew Pecora, MD
Dr. Andrew Pecora, MD is a Hematology healthcare provider based in Hackensack, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770544504.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Pecora, MD has received a total of $1.4M in payments from pharmaceutical and medical device companies, with $19.40 received in 2024. These payments were reported across 115 transactions from 12 companies. The most common payment nature is "Consulting Fee" ($1.3M).
As a Medicare-enrolled provider, Pecora has provided services to 2,737 Medicare beneficiaries, totaling 8,544 services with total Medicare billing of $741,759. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Other Specialties Medical Oncology
- Location Hackensack, NJ
- Active Since 03/31/2006
- Last Updated 01/26/2022
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1770544504
Products in Payments
- KEYTRUDA (Biological) $3,793
- Lenvima (Drug) $2,000
- TAFINLAR (Drug) $856.82
- Non-Covered Product (Drug) $73.37
- MEKINIST (Drug) $62.71
- Erivedge (Biological) $40.09
- Bavencio (Biological) $38.46
- ZYTIGA (Drug) $26.65
- Abraxane (Drug) $25.48
- KISQALI (Drug) $15.33
- Erleada (Drug) $14.99
- Aranesp (Biological) $14.86
- Xermelo (Drug) $14.04
- DARZALEX (Biological) $11.68
- IMLYGIC (Biological) $11.21
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Hackensack
Dr. James Mccloskey, M.d, M.D
Hematology — Payments: $2.8M
Hematology $2.8M
Dr. Jamie Koprivnikar, M.d, M.D
Hematology — Payments: $1.5M
Hematology $1.5M
Dr. David Vesole, Md, MD
Hematology — Payments: $1.1M
Hematology $1.1M
Dr. Lori Leslie, M.d, M.D
Hematology — Payments: $669,511
Hematology $669,511
Dr. Robert Alter, Md, MD
Hematology — Payments: $539,884
Hematology $539,884
Dr. David Siegel, Md, MD
Hematology — Payments: $469,559
Hematology $469,559